Related Experiment Video
Updated: Apr 17, 2026
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Erythropoietin acts as an anti-inflammatory signal on murine mast cells
Tanja Wiedenmann1, Stefanie Ehrhardt1, Daniela Cerny1
1Universitätsklinikum Heidelberg, Zentrum für Infektiologie, Medizinische Mikrobiologie und Hygiene, Germany.
Abstract:
Recently it was found that the erythropoietin receptor (EpoR) is expressed on innate immune cells, such as dendritic cells and macrophages. We found that murine bone marrow-derived mast cells express the EpoR and that its expression is increased under hypoxic conditions. Interestingly, Epo stimulation of the cells did not activate signal transducer and activator of transcription molecules, nor did we find differences in the expression of typical STAT-dependent genes, the proliferation rate, and the ability to differentiate or to protect the cells from apoptosis. Instead, we demonstrate that stimulation of mast cells with Epo leads to phosphorylation of the receptor tyrosine kinase c-kit. We hypothesize that this is due to the formation of a receptor complex between the EpoR and c-kit. The common beta chain of the IL-3 receptor family, which was described as part of the tissue protective receptor (TPR) on other non-erythroid cells, however is not activated. To investigate whether the EpoR/c-kit complex has tissue protective properties, cells were treated with the Toll-like receptor ligand LPS. Combined Epo and LPS treatment downregulated the inflammatory response of the cells as detected by a decrease in IL-6 and TNF-α secretion.
Insights
Erythropoietin receptor (EpoR) on mast cells interacts with c-kit, not STAT pathways. This EpoR/c-kit complex reduces inflammatory responses when stimulated with LPS, suggesting a novel immunomodulatory role for EpoR.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Erythropoietin receptor (EpoR) is expressed on innate immune cells like dendritic cells and macrophages.
- EpoR expression increases in mast cells under hypoxic conditions.
Purpose of the Study:
- To investigate the function of EpoR in murine bone marrow-derived mast cells.
- To determine the signaling pathways activated by Epo stimulation in mast cells.
- To explore the potential tissue-protective role of the EpoR/c-kit complex.
Main Methods:
- Mast cells were cultured and stimulated with erythropoietin (Epo).
- Expression of EpoR and STAT-dependent genes was analyzed.
- Phosphorylation of c-kit and activation of the IL-3 receptor family common beta chain were assessed.
- Cells were treated with Epo and LPS to evaluate inflammatory cytokine secretion.
Main Results:
- Epo stimulation of mast cells did not activate STAT molecules or affect STAT-dependent gene expression, proliferation, differentiation, or apoptosis.
- Epo stimulation led to the phosphorylation of the receptor tyrosine kinase c-kit, suggesting EpoR/c-kit complex formation.
- The common beta chain of the IL-3 receptor family was not activated.
- Combined Epo and LPS treatment downregulated the inflammatory response, indicated by decreased IL-6 and TNF-α secretion.
Conclusions:
- EpoR in mast cells signals through c-kit, not STAT pathways.
- The EpoR/c-kit complex may possess tissue-protective properties by modulating inflammatory responses.
- EpoR represents a potential therapeutic target for inflammatory conditions involving mast cells.
More Related Videos
08:25An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
Published on: April 27, 2021
11:31Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
Published on: July 4, 2018
Related Concept Videos
01:28Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
01:01Regulation of Hematopoietic Stem Cells
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...